Welcome to Seacross Pharmaceuticals Ltd.
Oncology Injectable Other Product 1 Other Product 2
Bendamustine Hydrochloride 2.5 mg/ml

Therapeutic indications: 

Bendamustine Hydrochloride is a medicine which is used for the treatment of certain types of cancer (cytotoxic medicine).

Bendamustine Hydrochloride is used alone (monotherapy) or in combination with other medicines for the treatment of the following forms of cancer:

• chronic lymphocytic leukaemia in cases where fludarabine combination chemotherapy is not appropriate for you,

• non-Hodgkin lymphomas, which had not, or only shortly, responded to prior rituximab treatment, 

• multiple myeloma in cases where thalidomide or bortezomib containing therapy is not appropriate for you. 

Form Powder for concentrate for solution for infusion
Strength 25mg/vial, 100mg/vial
Active substance Bendamustine Hydrochloride
Other ingredients Mannitol and hydrochloric acid
© Copyright - Clinico fusce blandit sapien eu